Escalating Dose Methamphetamine Pretreatment Alters the Behavioral and Neurochemical Profiles Associated with Exposure to a High-Dose Methamphetamine Binge
- 22 May 2003
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 28 (10), 1730-1740
- https://doi.org/10.1038/sj.npp.1300247
Abstract
The neurotoxic effects of methamphetamine (METH) have been characterized primarily from the study of high-dose binge regimens in rodents. However, this drug administration paradigm does not include a potentially important feature of stimulant abuse in humans, that is, the gradual escalation of stimulant doses that frequently occurs prior to high-dose exposure. We have argued that pretreatment with escalating doses (EDs) might significantly alter the neurotoxic profile produced by a single high-dose binge. In the present study, we tested this hypothesis by pretreating rats with saline or gradually increasing doses of METH (0.1–4.0 mg/kg over 14 days), prior to an acute METH binge (4 6 mg/kg at 2 h intervals). These animals, whose behavior was continuously monitored throughout drug treatment, were then killed 3 days later for determination of caudate-putamen dopamine (DA) content, levels of [3H]WIN 35,428 binding to the DA transporter, and levels of [3H]dihydrotetrabenazine ([3H]DTBZ) binding to the vesicular monoamine transporter. ED pretreatment markedly attenuated the stereotypy response, as well as the hyperthermia and indices of sympathetic activation associated with the acute binge. In addition, ED pretreatment prevented the decline in [3H]WIN 35,428 binding, and significantly diminished the decrease in DA levels, but did not affect the decrease in [3H]DTBZ binding associated with the acute binge. We suggest that further study of the effects produced by a regimen which includes a gradual escalation of doses prior to high-dose METH binge exposure could more accurately identify the neurochemical and behavioral changes relevant to those that occur as a consequence of high-dose METH abuse in humans.Keywords
This publication has 62 references indexed in Scilit:
- Loss of Striatal Vesicular Monoamine Transporter Protein (VMAT2) in Human Cocaine UsersAmerican Journal of Psychiatry, 2003
- Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic DeficitsJournal of Pharmacology and Experimental Therapeutics, 2002
- Analysis of VMAT2 Binding After Methamphetamine or MPTP TreatmentJournal of Neurochemistry, 2000
- Mechanisms for tolerance to methamphetamine effectsNeuropharmacology, 1996
- Qualitative and quantitative high performance liquid chromatographic analysis of monoamine neurotransmitters and metabolites in cerebrospinal fluid and brain tissue using reductive electrochemical detectionBiomedical Chromatography, 1990
- Long-term effects of chronic methamphetamine administration in rhesus monkeysBrain Research, 1989
- Methamphetamine-Induced Depression of Monoamine Synthesis in the Rat: Development of ToleranceJournal of Neurochemistry, 1985
- Recent Advances in the Endocrinology of PubertyEndocrine Reviews, 1980
- Tolerance development to chronic methamphetamine intoxication in the Rhesus monkeyPharmacology Biochemistry and Behavior, 1974
- Brain monoamine levels and behaviour during long-term administration of reserpineInternational Journal of Neuropharmacology, 1964